project id: TCGA-MESO; case submitter id: TCGA-ZN-A9VW; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 9.6; age at index: 61; days to birth: -22588; days to death: 84; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1949; year of death: 2010; age at diagnosis: 22588; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9053/3; primary diagnosis: Mesothelioma, biphasic, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1246; initial weight: 200.0; sample id: d9bd04f9-42b6-4dbd-a770-0fa5da681290; sample submitter id: TCGA-ZN-A9VW-01A; portion id: fd0fe6ac-a9a2-42d4-b678-bcc711fddb82; portion submitter id: TCGA-ZN-A9VW-01A-11; slide id: 732f2e47-8499-4c7f-b398-8b9a2bb5c826; slide submitter id: TCGA-ZN-A9VW-01A-01-TSA; percent lymphocyte infiltration: 60.0; percent monocyte infiltration: 10.0; percent necrosis: 10.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;